United States · FDA National Drug Code directory
ropivacaine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25021-671_41f4446a-ca6e-465e-9a79-8c4f99eb1ac3
- Product NDC
- 25021-671
- Form
- INJECTION, SOLUTION
- Composition / generic term
- ropivacaine hydrochloride
- Labeler
- Sagent Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20181215
- Source listing expiry
- 20271231
Source-listed ingredients
- ROPIVACAINE HYDROCHLORIDE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BAG in 1 CARTON (25021-671-82) / 100 mL in 1 BAG · 25021-671-82
- 10 BAG in 1 CARTON (25021-671-87) / 200 mL in 1 BAG · 25021-671-87
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →